Step count and treatment response in breast cancer patients
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how your daily step count, measured by a smartwatch, relates to how well your breast cancer responds to treatment before surgery. It may help show if being more active during chemotherapy leads to better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with breast cancer that has not spread to other parts of the body and is not HER2-positive.
- You are scheduled to receive chemotherapy or other systemic therapy before surgery.
- You are able to walk and do daily activities (ECOG score 0-2).
- You are willing to wear a smartwatch during the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartwatch to track your physical activity and see if it helps reduce tiredness after finishing chemotherapy. It is for people who finished treatment for certain cancers less than 3 months ago.
This study tests whether using a smartwatch and getting reminders can help people with colorectal cancer who are having chemotherapy become more active and sit less. It aims to see if these tools improve physical activity and overall well-being during treatment.
This study tests whether using a smartwatch to track daily activity can encourage more movement and help manage symptoms like weakness, numbness, or memory problems in people receiving cancer treatment for a brain tumor.
This trial tests whether using a Fitbit smartwatch to track your vital signs (like heart rate) can help catch problems early in people with stomach or esophageal cancer starting chemotherapy. You'll wear the watch and your care team will monitor the data to see if it improves safety and outcomes.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This study tests whether wearing a fitness tracker (like a step counter) is a practical way to measure how active you are while you are in an early-phase cancer clinical trial. It will help researchers see if this is something they can use in future trials.
Hear when a new Breast Neoplasm Malignant Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.